How drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.
Natalie Harb
Advertisement
Vice President, Offering Development, Global Commercial Solutions, IQVIA
Articles by Natalie Harb
Advertisement
Latest Updated Articles
The Future of Launch Excellence is Generative AIPublished: August 15th 2024 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
Bob Mauch: Strengthening the Chain
3
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
4
mRNA Covid Vaccines Display Potential to Benefit Immunotherapy Cancer Drugs
5
